-
1.
公开(公告)号:US20070275983A1
公开(公告)日:2007-11-29
申请号:US11779050
申请日:2007-07-17
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhenmin He , Ray James , Haengsoon Park
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhenmin He , Ray James , Haengsoon Park
IPC分类号: A61K31/519 , A61K38/14 , A61K31/704 , A61K31/7072 , A61K31/52
CPC分类号: C07D487/04 , A61K31/519 , A61K31/52 , A61K31/704 , A61K31/7072 , A61K45/06 , A61K2300/00
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的吡唑并[1,5-a]嘧啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。
-
2.
公开(公告)号:US20080050384A1
公开(公告)日:2008-02-28
申请号:US11788847
申请日:2007-04-20
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhenmin He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs , Paul Kirschmeier , Rajat Bannerji
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhenmin He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs , Paul Kirschmeier , Rajat Bannerji
IPC分类号: A61K31/519 , A61K31/33 , A61K31/4965 , A61K31/56 , A61K31/675 , A61K33/24 , A61K38/46 , A61P19/02 , A61P35/00 , A61P43/00 , A61P29/00 , A61K39/395 , A61K33/36 , A61K31/7004 , A61K31/655 , A61K31/535 , A61K31/497
CPC分类号: A61K31/33 , A61K31/4965 , A61K31/497 , A61K31/519 , A61K31/535 , A61K31/555 , A61K31/56 , A61K31/655 , A61K31/675 , A61K31/7004 , A61K33/24 , A61K45/06 , A61K2300/00
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的吡唑并[1,5-a]嘧啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。
-
公开(公告)号:US20070054925A1
公开(公告)日:2007-03-08
申请号:US11396079
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D487/04 , A61K31/495
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
-
4.
公开(公告)号:US20070054906A1
公开(公告)日:2007-03-08
申请号:US11396001
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
IPC分类号: A61K31/5377 , A61K31/519 , C07D487/04
CPC分类号: C07D487/04
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的吡唑并[1,5-a]嘧啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。
-
公开(公告)号:US20060173016A1
公开(公告)日:2006-08-03
申请号:US11395824
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
IPC分类号: A61K31/517 , C07D487/04
CPC分类号: C07D487/04 , A61K31/519 , A61K31/52 , A61K31/704 , A61K31/7072 , A61K45/06 , A61K2300/00
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
-
公开(公告)号:US20060178371A1
公开(公告)日:2006-08-10
申请号:US11395676
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Carmen Alvarez , Tin-Yau Chan , Chad Knutson , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Carmen Alvarez , Tin-Yau Chan , Chad Knutson , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
IPC分类号: A61K31/519 , A61K31/7048 , A61K31/704 , A61K31/525 , A61K31/66 , C07D487/04
CPC分类号: C07D487/04
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
-
公开(公告)号:US20070037824A1
公开(公告)日:2007-02-15
申请号:US10654546
申请日:2003-09-03
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Alan Mallams , Carmen Alvarez , Kartik Keertikar , Jocelyn Rivera , Tin-Yau Chan , Vincent Madison , Thierry Fischmann , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park , Vidyadhar Paradkar , Douglas Hobbs
IPC分类号: A61K31/519 , C07D487/02
CPC分类号: C07D487/04
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
-
公开(公告)号:US20060235025A1
公开(公告)日:2006-10-19
申请号:US11395974
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Lawrence Dillard , Vinh Tran , Zhen He , Ray James , Haengsoon Park
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D487/04
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
-
9.
公开(公告)号:US20060173017A1
公开(公告)日:2006-08-03
申请号:US11395965
申请日:2006-03-31
申请人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Chad Knutson , Brian McKittrick , Lawrence Dillard , Vinh Tran , Zhen Min He , Ray James , Haengsoon Park
发明人: Timothy Guzi , Kamil Paruch , Michael Dwyer , Ronald Doll , Viyyoor Girijavallabhan , Chad Knutson , Brian McKittrick , Lawrence Dillard , Vinh Tran , Zhen Min He , Ray James , Haengsoon Park
IPC分类号: A61K31/519 , C07D487/04
CPC分类号: C07D487/04
摘要: In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
摘要翻译: 在其许多实施方案中,本发明提供了一类新颖的吡唑并[1,5-a]嘧啶化合物作为细胞周期蛋白依赖性激酶的抑制剂,制备此类化合物的方法,含有一种或多种此类化合物的药物组合物,制备药物制剂的方法 包括一种或多种这样的化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CDK相关的一种或多种疾病的方法。
-
10.
公开(公告)号:US20080051423A1
公开(公告)日:2008-02-28
申请号:US11843897
申请日:2007-08-23
申请人: Jeffrey Letourneau , Vidyahar Paradkar , Michael Ohlmeyer , Lawrence Dillard , John Baldwin , Christopher Riviello , Angela Wong , Yaing Rong
发明人: Jeffrey Letourneau , Vidyahar Paradkar , Michael Ohlmeyer , Lawrence Dillard , John Baldwin , Christopher Riviello , Angela Wong , Yaing Rong
IPC分类号: C07D235/06 , A61K31/4184 , A61K31/428 , A61K31/47 , A61K31/4985 , A61P19/00 , C07D487/02 , C07D277/82 , A61P27/00 , A61P3/00 , A61P35/00 , C07D215/38
CPC分类号: C07D215/38 , C07D235/30 , C07D401/12 , C07D403/12 , C07D405/12 , C07D487/04
摘要: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed. A representative example is
摘要翻译: 具有羧酸酯末端的氮杂环联芳烃可用于治疗子宫内膜异位症,骨质疏松症,血管成形术后的再狭窄,类风湿性关节炎,癌症,黄斑变性和肥胖症。 公开了式的化合物。 一个代表性的例子是
-
-
-
-
-
-
-
-
-